# OnCo record mlsg15-mogamulizumab-atll (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/mlsg15-mogamulizumab-atll/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "mlsg15-mogamulizumab-atll", "NCT01173887" ;
  schema:name "mLSG15 with or without mogamulizumab"@en ;
  schema:alternateName "mLSG15 plus KW-0761"@en, "Ishida 2015"@en ;
  schema:description "Adding mogamulizumab to the intensive Japanese chemotherapy for newly diagnosed adult T-cell leukaemia raised the complete remission rate, at the cost of more side effects, including infections and lung inflammation."@en ;
  schema:url <https://onco.cc/trials/mlsg15-mogamulizumab-atll/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01173887>, <https://doi.org/10.1111/bjh.13338> ;
  onco:status "mixed" ;
  onco:tag "lymphoma-evidence-entities" ;
  onco:phase "2" ;
  schema:startDate "2010-07" ;
  onco:cancers <https://onco.cc/cancers/adult-t-cell-leukaemia-lymphoma/>, <https://onco.cc/cancers/peripheral-t-cell-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/>, <https://onco.cc/fronts/chemotherapy/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:targets <https://onco.cc/targets/ccr4/> ;
  onco:drugs <https://onco.cc/drugs/mogamulizumab/>, <https://onco.cc/drugs/vincristine/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/prednisone/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/carboplatin/> ;
  onco:companies <https://onco.cc/companies/kyowa-kirin/> ;
  onco:terms <https://onco.cc/terms/complete-response/>, <https://onco.cc/terms/lymphoma-htlv-1/> ;
  onco:trials <https://onco.cc/trials/jcog9801/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-mlsg15-mogamulizumab-atll-bjh-2015/> .